Clinical Trials Logo

Amphetamine-related Disorders clinical trials

View clinical trials related to Amphetamine-related Disorders.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03318081 Recruiting - Clinical trials for Amphetamine Addiction

The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction

Start date: October 20, 2017
Phase: N/A
Study type: Interventional

The computerized cognitive rehabilitation therapy will be used to treat amphetamine-type stimulant (ATS) addiction.

NCT ID: NCT02713815 Recruiting - Clinical trials for Amphetamine Addiction

Novel Intervention for Amphetamine-type Stimulants Addiction

Start date: July 2016
Phase: N/A
Study type: Interventional

The motivational-cognitive psychotherapy and repetitive transcranial magnetic stimulation (rTMS) will be used to treat amphetamine-type stimulant (ATS) addiction.

NCT ID: NCT02541526 Recruiting - Heroin Dependence Clinical Trials

Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia

Start date: May 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate tolerability, acceptability and potential efficacy of 4 months of maintenance treatment with Mirtazapine as compared to placebo for patients with co-occurring amphetamine-type stimulant and opioid dependence (COATS) receiving buprenorphine maintenance treatment (BMT) in Kota Bharu.

NCT ID: NCT02541500 Recruiting - Heroin Dependence Clinical Trials

An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence

Start date: April 2013
Phase: Phase 3
Study type: Interventional

The proposed study will evaluate the tolerability, acceptability and potential efficacy of minocycline for the treatment of co-occurring opioid and amphetamine-type stimulant (ATS) dependence. In the proposed clinical trial, all patients will first discontinue illicit opioid and ATS and be inducted onto buprenorphine maintenance treatment (BMT) in the inpatient ward at the department of psychiatry before beginning to receive minocycline. Tolerability and acceptability will be evaluated by assessing the rates of patient retention during treatment, patient satisfaction with treatment and adverse effects during treatment. The potential efficacy of minocycline will be evaluated with regard to the primary outcome measure: reductions in ATS use , based on urine toxicology testing and self-report. Secondary outcome measures include retention, reduction in HIV risk behaviors and improvements in functional status.

NCT ID: NCT01899313 Recruiting - Clinical trials for Amphetamine-Related Disorders

A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence

Start date: May 2014
Phase: N/A
Study type: Interventional

This Phase I behavior therapy development study seeks to improve treatment outcomes for methamphetamine (MA)-dependent subjects by developing a novel cognitive behavioral therapy- (CBT-) based short message service (SMS) text messaging intervention.